Go to main content

FDA

Zepbound

Zepbound (Tirzepatide) FDA-Approved for Chronic Weight Management

FDA Authorizes First Digital Therapy App for Type 2 Diabetes Management

FDA-approved AspyreRx is a digital therapy app for type 2 diabetes that uses CBT to boost wellness and glucose management via smartphone.

FDA Approves Farxiga in US for Chronic Heart Failure

Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication. 

Rybelsus, the First GLP-1 Pill, Approved for Type 2 Diabetes in Europe

Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on Saturday

Dietary Supplement Companies Are Making False Claims, FDA and FTC Warns

The FDA and the FTC sent warning letters to 10 companies falsely claiming to sell dietary supplements that could cure, treat, mitigate, or prevent diabetes. People are strongly encouraged to avoid these products until they have undergone the proper testing.

FDA Issues Strong Safety Warning Against Shasta GenStrip